News & Updates

Preoperative treatment with tofacitinib results in adverse events (AEs) rates in the postoperative setting that are similar to that with biologic therapy among patients with ulcerative colitis (UC) undergoing colectomy, a study has shown.

Mass vaccination with a recombinant zoster vaccine (RZV) may decrease the burden of herpes zoster (HZ) or shingles in older adults in Singapore (SG), a study suggests.

Adding isatuximab to bortezomib, lenalidomide, and dexamethasone (VRd) regimen provides a significant progression-free survival (PFS) benefit in patients with newly diagnosed multiple myeloma (NDMM) who were ineligible to undergo transplantation compared with VRd alone, according to a prespecified interim analysis of the phase III IMROZ trial presented at EHA 2024.

Patients who filled an opioid prescription following an ophthalmic surgery have higher likelihood of mortality, hospitalization, opioid overdose, and opioid dependence than those who did not fill a prescription, reports a study.

The use of long-acting injectable cabotegravir (CAB-LA) as a pre-exposure prophylaxis (PrEP) during pregnancy appears to be safe and well tolerated in cisgender women, according to the initial data of HPTN* 084 open-label extension (OLE) study presented at AIDS 2024.